Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Taxes (2016 - 2017)

Amphastar Pharmaceuticals has reported Change in Taxes over the past 5 years, most recently at -$2.5 million for Q3 2017.

  • Quarterly results put Change in Taxes at -$2.5 million for Q3 2017, down 351.29% from a year ago — trailing twelve months through Sep 2017 was -$5.8 million (down 236.88% YoY), and the annual figure for FY2015 was -$92000.0, down 116.46%.
  • Change in Taxes for Q3 2017 was -$2.5 million at Amphastar Pharmaceuticals, up from -$3.2 million in the prior quarter.
  • Over the last five years, Change in Taxes for AMPH hit a ceiling of $6.0 million in Q4 2014 and a floor of -$5.4 million in Q3 2014.
  • Median Change in Taxes over the past 5 years was -$193500.0 (2015), compared with a mean of -$314500.0.
  • Biggest five-year swings in Change in Taxes: surged 15137.5% in 2014 and later tumbled 351.29% in 2017.
  • Amphastar Pharmaceuticals' Change in Taxes stood at -$40000.0 in 2013, then surged by 15137.5% to $6.0 million in 2014, then plummeted by 83.52% to $991000.0 in 2015, then tumbled by 154.89% to -$544000.0 in 2016, then tumbled by 351.29% to -$2.5 million in 2017.
  • The last three reported values for Change in Taxes were -$2.5 million (Q3 2017), -$3.2 million (Q2 2017), and $394000.0 (Q1 2017) per Business Quant data.